1.  Beijing has eased access for foreign investors to establish non-profit elderly care facilities as private non-enterprise entities through donations.

2.  The city supports the establishment of international research-oriented hospitals and R&D projects for hospital beds.

3.  A 'white list' system has been established in Beijing for the import of biomedical R&D materials.

4.  Confidential review of patent applications abroad has been streamlined, with the review time-frame for innovative drug inventors reduced from one month to about one week.

5.  An innovative one-stop centralized inspection system for biological reagents has been introduced, allowing for an intelligent review model that enables immediate inspection upon arrival for those requiring strict temperature control, significantly expediting the review time for health quarantine.